Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,826 | -48,397 | -177,119 | -127,363 | -76,838 |
| Depreciation Amortization | 1,325 | 661 | 2,328 | 1,563 | 794 |
| Accounts receivable | -1,610 | -516 | -982 | -290 | -657 |
| Accounts payable and accrued liabilities | -3,198 | -9,108 | 6,454 | 9,108 | 2,995 |
| Other Working Capital | -7,220 | -11,470 | 2,659 | 6,936 | -916 |
| Other Operating Activity | 8,859 | 13,700 | 4,763 | -1,303 | 4,892 |
| Operating Cash Flow | $-103,670 | $-55,130 | $-161,897 | $-111,349 | $-69,730 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -122,297 | -110,224 | -49,473 | -101,371 | -62,128 |
| PPE Investments | -250 | N/A | -470 | -470 | -387 |
| Investing Cash Flow | $-122,547 | $-110,224 | $-49,943 | $-101,841 | $-62,515 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 49,961 | 49,962 | 49,961 |
| Common Stock Issued | 89 | 88 | 138,823 | 138,823 | 139,034 |
| Common Stock Repurchased | -1,730 | -1,730 | -824 | -824 | -824 |
| Other Financing Activity | 241,010 | 241,025 | 0 | 0 | 0 |
| Financing Cash Flow | $239,369 | $239,383 | $187,960 | $187,961 | $188,171 |
| Beginning Cash Position | 22,465 | 22,465 | 46,345 | 46,345 | 46,345 |
| End Cash Position | 35,617 | 96,494 | 22,465 | 21,116 | 102,271 |
| Net Cash Flow | $13,152 | $74,029 | $-23,880 | $-25,229 | $55,926 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,670 | -55,130 | -161,897 | -111,349 | -69,730 |
| Capital Expenditure | -250 | N/A | -470 | -470 | -387 |
| Free Cash Flow | -103,920 | -55,130 | -162,367 | -111,819 | -70,117 |